1469-896X/asset/olbannerleft.gif?v=1&s=d218899ae53b2862ab119790ed504b8d72122fb3)
1469-896X/asset/olbannerright.gif?v=1&s=59470eb9a1d9b7b13b1be75e9445e6c46ee2214f)
Article
You have full text access to this OnlineOpen article
Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn
Article first published online: 29 DEC 2008
DOI: 10.1002/pro.45
Copyright © 2008 The Protein Society
Additional Information
How to Cite
Pan, H., Chen, K., Chu, L., Kinderman, F., Apostol, I. and Huang, G. (2009), Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Science, 18: 424–433. doi: 10.1002/pro.45
Publication History
- Issue published online: 30 JAN 2009
- Article first published online: 29 DEC 2008
- Manuscript Accepted: 17 NOV 2008
- Manuscript Revised: 6 NOV 2008
- Manuscript Received: 5 AUG 2008
References
- 1( 2000) Quantification and significance of protein oxidation in biological samples. Drug Metab Rev 32: 307–326.
- 2, , ( 1994) Regulation of oxidative degradation of L-lysine in rat liver mitochondria. Biochem J 300(Pt 3): 887–891.
- 3, ( 2001) Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition. J Pharm Sci 90: 253–269.Direct Link:
- 4, , ( 2005) Single-site oxidation, cysteine 108 to cysteine sulfinic acid, in D-amino acid oxidase from Trigonopsis variabilis and its structural and functional consequences. Appl Environ Microbiol 71: 8061–8068.
- 5, , , , , , ( 1999) Chemical modification and site-directed mutagenesis of methionine residues in recombinant human granulocyte colony-stimulating factor: effect on stability and biological activity. Arch Biochem Biophys 362: 1–11.
- 6, , , ( 2002) Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol Cell Biochem 234–235: 3–9.
- 7, ( 1986) The role of the methionine residues in the structure and function of parathyroid hormone. Arch Biochem Biophys 244: 641–649.
- 8, , , , , , ( 1987) Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities. J Biol Chem 262: 6472–6477.
- 9, , , ( 1989) Oxidation of methionine residues of recombinant human interleukin 2 in aqueous solutions. Chem Pharm Bull (Tokyo) 37: 2160–2164.
- 10, , ( 1997) Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. J Pharm Sci 86: 1250–1255.Direct Link:
- 11, , , , , , , ( 1998) Loss of conformational stability in calmodulin upon methionine oxidation. Biophys J 74: 1115–1134.
- 12, , , , , , ( 1998) In vitro methionine oxidation of recombinant human leptin. Pharm Res 15: 632–640.
- 13, , , , , ( 2002) Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Lett 517: 239–244.
- 14, , , , ( 2003) NMR structures reveal how oxidation inactivates thrombomodulin. Biochemistry 42: 11932–11942.
- 15, , ( 2005) Structural uncoupling between opposing domains of oxidized calmodulin underlies the enhanced binding affinity and inhibition of the plasma membrane Ca-ATPase. Biochemistry 44: 4737–4747.
- 16, , ( 2006) Methionine oxidation of monomeric lambda repressor: the denatured state ensemble under nondenaturing conditions. Protein Sci 15: 533–542.Direct Link:
- 17, ( 1983) Biochemistry and physiological role of methionine sulfoxide residues in proteins. Arch Biochem Biophys 223: 271–281.
- 18, , , , , , , , , , et al ( 1992) Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest 90: 2565–2573.
- 19, , , ( 1997) Oxidation of a critical methionine modulates DNA binding of the Drosophila melanogaster high mobility group protein, HMG-D. FEBS Lett 414: 514–520.
- 20, , ( 1999) Oxidation of methionine residues in coagulation factor VIIa. Arch Biochem Biophys 363: 43–54.
- 21, ( 2003) Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2: 52–62.
- 22( 2007) Monoclonal antibody “gold rush”. Curr Med Chem 14: 1978–1987.
- 23( 1985) Immunoglobulin G: functional sites. Mol Immunol 22: 161–206.
- 24( 2006) Potent antibody therapeutics by design. Nat Rev 6: 343–357.
- 25( 1977) Structural studies on the four repetitive Fc-binding regions in protein A from Staphylococcus aureus. Eur J Biochem 78: 471–490.Direct Link:
- 26, , ( 1994) Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372: 379–383.
- 27( 1982) Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol 32: 157–252.
- 28, , , , , ( 1986) Staphylococcal protein A consists of five IgG-binding domains. Eur J Biochem 156: 637–643.Direct Link:
- 29, ( 1989) An Fc receptor structurally related to MHC class I antigens. Nature 337: 184–187.
- 30, ( 2000) Multiple roles for the major histocompatibility complex class I-related receptor FcRn. Annu Rev Immunol 18: 739–766.
- 31, ( 2007) FcRn: the neonatal Fc receptor comes of age. Nat Rev 7: 715–725.
- 32
- 33, , ( 2004) Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 93: 2645–2668.Direct Link:
- 34, , , ( 1996) The application of tert-butylhydroperoxide oxidation to study sites of potential methionine oxidation in a recombinant antibody. Tech Protein Chem 7: 275–284.
- 35, , , ( 2007) Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody. J Chromatogr 850: 285–294.
- 36, , , , , , , , ( 2008) Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. Biochemistry 47: 5088–5100.
- 37, ( 2007) WHAT IF. Available at: http://swift.cmbi.kun.nl/WIWWWI/ accessed March 2008.
- 38, , ( 2007) Protein A chromatography for antibody purification. J Chromatogr 848: 40–47.
- 39, , , , ( 2007) Downstream processing of monoclonal antibodies—application of platform approaches. J Chromatogr 848: 28–39.
- 40, , , , ( 2008) Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G. J Chromatogr 870: 55–62.
- 41( 1981) Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry 20: 2361–2370.
- 42, , , , , ( 1993) 13C NMR study of the mode of interaction in solution of the B fragment of staphylococcal protein A and the Fc fragments of mouse immunoglobulin G. FEBS Lett 328: 49–54.
- 43, ( 1999) Characterization of the 2:1 complex between the class I MHC-related Fc receptor and its Fc ligand in solution. Biochemistry 38: 12639–12647.
- 44, ( 2000) Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor. Biochemistry 39: 9698–9708.
- 45, , , ( 2001) Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol Cell 7: 867–877.
- 46, , , , , , , , , , , ( 2001) High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem 276: 6591–6604.
- 47, , , , , , , , ( 2002) Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences. J Immunol 169: 5171–5180.
- 48, , , , , , , , , , ( 2004) Engineered human IgG antibodies with longer serum half-lives in primates. J Biol Chem 279: 6213–6216.
- 49, , , ( 2005) Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotechnol 23: 1283–1288.
- 50, , ( 2006) Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J Biol Chem 281: 23514–23524.
- 51, , , , , ( 2006) An engineered human IgG1 antibody with longer serum half-life. J Immunol 176: 346–356.
- 52, , , , , , , , ( 2006) Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol 18: 1759–1769.
- 53, , , ( 1995) Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. Structure 3: 265–278.
- 54, , , , , , , , ( 1997) Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol 4: 374–381.